Sequoia Insilico Private Ltd

Sequoia Insilico is a cognitive technology company that focused on the development of proprietary, clinically validated, multimodal data-driven Assitive diagnosis (Dx) Deep Learning (DL) applications for neurocognitive behavioural diseases, with an emphasis on patient-centered care. The potential of Dx Technology to revolutionise the mental health diagnosis landscape is truly remarkable. These transformative solutions possess immense potential to enhance mental health outcomes, diminish the prevailing stigma, and guarantee swift, precise, and customised care for individuals with mental health needs. Leveraging cutting-edge technology and fostering seamless collaboration within the mental healthcare industry, we aim to revolutionise the way mental health care is delivered, considering patient as participent and not mere care recipient. The applications serve as invaluable tools for clinicians, enabling them to optimise their workflow, save precious time, and enhance the effectiveness of treatments. Cognitive systems are on the verge of revolutionising global healthcare accessibility, making it more cost-effective, efficient, and reliable. Moreover, these systems will empower patients to take charge of their own well-being through self-care initiatives.